Articles

Dr. Arepalli discussed a course focused on ocular conditions related to pregnancy and postpartum care, presented at the American Academy of Ophthalmology (AAO) meeting.

At this year's American Academy of Ophthalmology (AAO) meeting, Jonathan Brugger, MD, spoke about the changing approach to epimacular membranes and the use of brilliant blue in the procedure.

Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.

Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.

Meghan Berkenstock, MD, an associate professor of ophthalmology at the Wilmer Eye Institute, provides insights on paper from the uveitis free paper section of AAO 2024, about the use of TriNetX database to assess for the incidence and prevalence of both uveitis and its complications.

Matt Giegengack, MD, explains how injectable corneal endothelial cell therapy can enhance visual acuity and alleviate glare, offering a versatile alternative to current treatments like DMEK.

George O. Waring, IV, MD, provides insights from an on-demand poster as part of the annual American Academy of Ophthalmology taking place in Chicago, Illinois. This poster was titled, "Two-Year Clinical Feasibility Trial Outcomes for a Dual-Optic IOL System for the Treatment of Presbyopia and Cataract."

In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma

Farhad Hafezi, FARVO, MD, PhD, and colleagues reported on results achieved with phototherapeutic keratectomy-assisted, customised, epi-on corneal crosslinking

At this year's American Academy of Ophthalmology (AAO) meeting, John Berdahl, MD, spoke about the recent clinical trials of travoprost and its use in patients with prior SLT.

A novel oral therapeutic showed promising results in a Phase 2 study involving 13 subjects

Abdelrahman Elhusseiny, MD, MSc, discusses his AAO presentation on risk of posterior capsular rupture in fellow-eyes cataract surgery

The research found that, in the classroom, when learning-focused cell phone use increased, social use decreased

This initiative is supported by a $5 million grant from the Knights Templar Eye Foundation.

A home self-imaging device can provide ophthalmologists with actionable insight between office visits for AMD

Non-invasive, painless laser can reduce risk of vision loss

A large study performed in Canada analyzed data and found that patients are at higher risk of multiple possible complications after cataract surgery.

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 AAO meeting

Gene therapy for nAMD represents significant advancements in the treatment of retinal conditions

The DOG recognised Heidelberg Engineering founder Christoph Schoess, Prof Herbert Kaufmann and Prof Ioannis G. Pallikaris

Meeting information to remember, including key locations and childcare options

The diverse list of sessions includes discussions of surgical ethics and an arts lecture about Ansel Adams

Attendees can choose from symposia, instructional courses, clinical sessions, original papers, skills transfer lectures, the Expo and more

Her Royal Highness will share the CBeebies Bedtime Story "Specs for Rex"

The Eye Care Network adds a longstanding, CME-certified conference to its live event programming

A retrospective analysis illuminates discrepancies between adult and paediatric cataract procedures around the globe

This year, the IAPB encourages children worldwide to love their eyes

How robotics and gene therapies are shaping retina research, now and in the days to come

Making the most of AI means letting go of fear, says Editorial Advisory Board member Johan Blanckaert, MD

The research findings highlighted a new therapeutic avenue in ocular and neurodegenerative disease